- Home
- NEON vs EBS Comparison
NEON vs EBS Comparison
Compare NEON & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEON
- EBS
- Stock Information
- Founded
- NEON 1997
- EBS 1998
- Country
- NEON Sweden
- EBS United States
- Employees
- NEON N/A
- EBS N/A
- Industry
- NEON Industrial Machinery/Components
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NEON Technology
- EBS Health Care
- Exchange
- NEON Nasdaq
- EBS Nasdaq
- Market Cap
- NEON 428.0M
- EBS 359.3M
- IPO Year
- NEON 2007
- EBS 2006
- Fundamental
- Price
- NEON $26.18
- EBS $7.30
- Analyst Decision
- NEON Strong Buy
- EBS Strong Buy
- Analyst Count
- NEON 1
- EBS 3
- Target Price
- NEON $16.50
- EBS $14.33
- AVG Volume (30 Days)
- NEON 763.4K
- EBS 1.4M
- Earning Date
- NEON 08-07-2025
- EBS 08-05-2025
- Dividend Yield
- NEON N/A
- EBS N/A
- EPS Growth
- NEON N/A
- EBS N/A
- EPS
- NEON N/A
- EBS N/A
- Revenue
- NEON $2,807,000.00
- EBS $965,400,000.00
- Revenue This Year
- NEON N/A
- EBS N/A
- Revenue Next Year
- NEON $39.01
- EBS $18.88
- P/E Ratio
- NEON N/A
- EBS N/A
- Revenue Growth
- NEON N/A
- EBS N/A
- 52 Week Low
- NEON $2.22
- EBS $4.02
- 52 Week High
- NEON $28.08
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NEON 69.54
- EBS 61.46
- Support Level
- NEON $24.31
- EBS $6.59
- Resistance Level
- NEON $28.08
- EBS $7.42
- Average True Range (ATR)
- NEON 2.04
- EBS 0.40
- MACD
- NEON -0.09
- EBS 0.06
- Stochastic Oscillator
- NEON 76.86
- EBS 75.76
About NEON Neonode Inc.
Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.